Navigation Links
Humphrey Matrix Perimeter

ProductsHumphrey Matrix Perimeter
Company Carl Zeiss Meditec, Inc.
Item Humphrey Matrix Perimeter
Features 
  • Excellent for characterizing glaucoma and providing a basic glaucoma management platform
  • Threshold and screening tests for comprehensive care
  • Patient management software including Glaucoma Asymmetry Test and serial field overview for comprehensive exam results
  • Clinical validation from numerous studies documenting the Matrix's ROC curve
  • Easy and intuitive operation for users of any ability
Description The Matrix Perimeter utilizes Welch Allyn Frequency Doubling Technology. It represents a significant breakthrough in visual field testing by combining early glaucoma detection capabilities, tools to characterize glaucoma and basic glaucoma management tools.

Like the Humphrey FDT Perimeter, the Matrix doubles as an in-office glaucoma screener with 35 second supra-threshold testing. And it provides up to 69 stimuli to characterize visual field defects to facilitate accurate diagnoses.

Info Carl Zeiss Meditec, Inc.Call Carl Zeiss Meditec, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6044

Customer Service: 877-486-7473
Web site: http://www.meditec.zeiss.com/

Related medicine products :

1. Humphrey Matrix
2. Humphrey Field Analyzer II - i series
3. Humphrey FDT Perimeter
4. Humphrey Atlas Corneal Topography Systems
5. Humphrey Refractor/Keratometer HARK 599
6. Model 350 Humphrey Lens Analyzer
7. Model 360 Humphrey Lens Analyzer
8. Humphrey Field Analyzer II - i series
9. Humphrey FDT Visual Field Instrument
10. Humphrey® Field Analyzer/HFA II-i
11. Humphrey GPA Glaucoma Progression Analysys Software
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products:
(Date:7/25/2008)...ter financial results -, LAVAL, QC, July 25 /PRNe...AQ: DDSS) today announced that it will host a conf...to discuss its second quarter 2008,financial resul...financial,results via news release at approximatel...ce call by telephone, dial 416-646-3095 or,1-800-8...
(Date:7/25/2008)...oviral therapy may be due to genetic factors , ... study challenges the long-held belief that the he...ability to restore itself after HIV patients are t...HAART). , From 50 percent to 90 percent of HIV-...travenous drug use is the main cause of both types...
(Date:7/25/2008)...American Society for Gastrointestinal Endoscopy (A...y in the bariatric surgery patient. The rising pre...ccess in surgical interventions led to a marked in...ormed in the U.S., from 13,365 in 1998 to 102,794 ...reoperative patient and the postoperative patient,...
(Date:7/25/2008)...mber of jobs created in the medical field slowed i...ent kind of slowdown: they laid off fewer people i... Seattle, WA (PRWEB) July 25, 2008 -- Thou... slowed in June overall, pharmaceutical companies ... music to the ears of sales representatives: fewer...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3
... patient in the world Isabelle Dinoire, appears to...ng wine, and consuming chocolate cake in large qua... after being disfigured by a mauling she received ...ncouraging her to eat well after the weight she ha...
...oblem for women and any food givig respite is welc...s performed on rats and their bone cells. The comp...myl peptide did wonders and being treated with par...resoprtion. So this study can greatly help women a...
...ic used to treat respiratory tract problems such a.../. Three patients taking the drug was reported to ...k. The three cases of ketek adverse effects as be...edicine. The three patients did not have any liver...
...cted by Jerald Greenberg professor of management a...her College of Business stated// that pay cuts res.... The study was conducted in 4 hospitals in differ...ospitals the nurses received a pay cut which reduc...
Other Medicine News:Health News:Pay Cut Leads To Increased Levels Of Insomnia Among Workers 2
(Date:7/24/2008)...ows Increased Muscle and Blood Vessel Formation in...ISE, Fla., July 24 /- Resul...of myoblasts modified to express,stromal derived f...e of the,myocardium of rats, which suggest improve...cientific meetings -- the International Society fo...
(Date:7/24/2008)...ment Program Speeds Oncology Patient Accrual, DEN...esearch Management,Organization (RMO), has contrac...provide research and site management services for ... enrollment strategy. The new,trials include the f...in,s,Lymphoma, Metastatic Breast Cancer, Metastati...
(Date:7/23/2008)...Approved Systemic Therapy to Treat the Disease -, ...wswire-FirstCall/ --,Bayer HealthCare Pharmaceutic...today announced that The New England Journal of Me...trating that Nexavar(R) (sorafenib),tablets decrea...tients with,unresectable hepatocellular carcinoma ...
(Date:7/23/2008)...Newswire/ -- FluoroPharma Inc., a company developi...ositron Emission Tomography,(PET) market, announce...uorine-18 labeled tracer for myocardial perfusion ...ular product to complete Phase I clinical,developm...ssess the blood flow in the,heart (myocardial perf...
Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3TeamStaff Inc Announces Results From Annual Meeting of Shareholders 17160 1TeamStaff Inc Announces Results From Annual Meeting of Shareholders 17160 2TeamStaff Inc Announces Results From Annual Meeting of Shareholders 17160 3Young Innovations Inc Provides First Quarter Conference Call Details 17158 1Young Innovations Inc Provides First Quarter Conference Call Details 17158 2Immucor CEOs Italian Trial Moves Toward Second Phase 4694 1Immucor CEOs Italian Trial Moves Toward Second Phase 4694 2Immucor CEOs Italian Trial Moves Toward Second Phase 4694 3Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 1Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 2Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 3Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 4
...ete Response or Reduction of,Lesion Size by More t... /PRNewswire-FirstCall/ - Nventa,Biopharmaceutical...positive results from a clinical trial examining t...investigational therapeutic,vaccine for human papi...he highest grade of cervical dysplasia (CIN III). ...
... 5, 2007 - Advanced Cell,Technology, Inc.,s (OTCBB... noted in Scientific American,s March 2007 issue a...l text of the article,which notes Advanced Cell,s...o transplantable retinal pigment epithelial (RPE),...ompany announced,its collaboration with the Casey ...
Other Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 2Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 3